NEULANDLAB.BONEULANDLAB.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.32% | -14.71% | -33.41% | +65.44% | +10.47% |
| Gross Profit Growth | -10.24% | -23.72% | +1.96% | +88.44% | -56.66% |
| EBITDA Growth | +18.58% | -46.47% | -71.54% | +136.40% | -41.77% |
| Operating Income Growth | -33.76% | -84.20% | -86.65% | +188.18% | -24.30% |
| Net Income Growth | +24.81% | -58.84% | -85.80% | +194.90% | -60.06% |
| EPS Growth | +24.81% | -58.85% | -85.80% | +194.88% | -60.07% |
| EPS Diluted Growth | +24.81% | -58.85% | -85.80% | +194.88% | -60.07% |
| Weighted Average Shares Growth | +0.00% | +0.00% | +0.03% | +0.01% | +0.00% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | +0.03% | +0.01% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -17.57% | +0.00% | +44.12% | +0.00% |
| Inventory Growth | +0.00% | +10.08% | +0.00% | +41.78% | +0.00% |
| Asset Growth | +0.00% | +18.95% | +0.00% | +30.36% | +0.00% |
| Book Value per Share Growth | +23.16% | +18.87% | +18.84% | +16.11% | +0.00% |
| Debt Growth | +0.00% | +64.73% | +0.00% | +141.60% | +0.00% |
| R&D Expense Growth | +0.00% | +13.36% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | -38.75% | -100.00% | +0.00% | +0.00% |